A randomised phase III study to evaluate the effectiveness prednisolone therapy for late stage Duchenne muscular dystrophy in maintaining lung function

Status

Terminated

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000076673

Enrollment

Registered

2005-08-05

Start date

2005-01-08

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study will assess if treatment with Prednisolone has a positive effect in maintaining lung function in non-ambulant boys with Duchenne muscular dystrophy

Interventions

12-month trial of Prednisolone on respiratory function in non-ambulatory boys with Duchenne muscular dystrophy.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

10 Years to No maximum

Healthy volunteers

Inclusion criteria

Duchenne muscular dystrophy, non-ambulant.

Exclusion criteria

No exclusion criteria

Outcome results